Eleni Karakike, Simeon Metallidis, Garyfallia Poulakou, Maria Kosmidou, Nikolaos K. Gatselis, Vasileios Petrakis, Nikoletta Rovina, Eleni Gkeka, Styliani Sympardi, Ilias Papanikolaou, Ioannis Koutsodimitropoulos, Vasiliki Tzavara, Georgios Adamis, Konstantinos Tsiakos, Vasilios Koulouras, Eleni Mouloudi, Eleni Antoniadou, Gykeria Vlachogianni, Souzana Anisoglou, Nikolaos Markou, Antonia Koutsoukou, Periklis Panagopoulos, Haralampos Milionis, George N. Dalekos,
Miltiades Kyprianou, Evangelos J. Giamarellos-Bourboulis
Critical Care Explorations 2024 Sep 10;6(9):e1153.
DOI: 10.1097/CCE.0000000000001Download pdf 🡇
Funding
The study was supported by the Hellenic Institute for the Study of Sepsis and by the Horizon 2020 grant “European Sepsis Academy” Marie Skłodowska-Curie International Training Network (grant number 676129- granted to the National and Kapodistrian University of Athens).
Keywords: COVID-19; immunotherapy; mortality; phenotypes; sepsis